首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1457994

全球心臟病學和神經病學 IVD 市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global IVD In Cardiology And Neurology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年03月01日 | 出版商:

Value Market Research | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球心臟病學和神經病學市場 IVD 需求預計將從 2023 年的 168.8 億美元達到近 395.7 億美元的市場規模，2024 年至 2032 年的研究期間CAGR為 9.93%。

心臟病學和神經病學中的體外診斷 (IVD) 是指對體外樣本進行診斷測試，以評估心臟和神經系統狀況。這些測試包括生物標記測量、遺傳分析和影像研究，有助於心血管和神經系統疾病的早期檢測、監測和治療計劃。

市場動態

心臟病學和神經病學領域的 IVD（體外診斷）市場受到全球心血管和神經系統疾病盛行率上升的推動。 IVD 設備的技術進步（例如生物標記發現和分子診斷）提高了診斷精度。醫療保健支出的增加、人口老化的加劇以及預防性醫療保健的積極舉措進一步刺激了市場擴張。此外，將人工智慧和資料分析整合到 IVD 設備中有助於個人化和高效的患者診斷。然而，市場限制包括與監管複雜性和新型診斷技術嚴格核准流程相關的挑戰。克服這些限制需要簡化監管途徑，並持續努力，使心臟病學和神經病學市場的醫療保健提供者更容易獲得先進的 IVD 技術，並更具成本效益。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球心臟病學和神經病學體外診斷市場的各個細分市場進行了包容性評估。體外診斷在心臟病學和神經病學行業的成長和趨勢為這項研究提供了整體方法。

市場區隔

心臟病學和神經病學市場報告中的 ivd 的這一部分提供了有關國家和地區級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

依產品類型

儀器
試劑及耗材
軟體與服務

依技術

免疫測定
分子診斷
血液學
其他

按最終用途

醫院
臨床實驗室
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲心臟病學和神經病學 IVD 市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

全球心臟病學和神經病學 IVD 市場佔有率（按地區）（代表性圖）
全球心臟病學和神經病學 IVD 市場佔有率

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。心臟病學和神經病學IVD 市場的主要參與者包括Thermo Fisher Scientific Inc.、F. Hoffmann-La Roche Ltd.、Sysmex Corp.、Siemens Healthineers AG、Quest Diagnostics Inc.、Abbott, BD、Bio-Rad Laboratories, Inc. ., Beckman Coulter, Inc.本部分包含競爭格局的整體視圖，其中包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概覽、協作、新產品開發、新產品發布以及其他事態發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：心臟病學和神經病學公司 IVD 的競爭格局

Ivd 參與心臟病學和神經病學市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Thermo Fisher Scientific Inc.

公司簡介
公司收入
產品
最近的發展

F. Hoffmann-La Roche Ltd.

公司簡介
公司收入
產品
最近的發展

Sysmex Corp.

公司簡介
公司收入
產品
最近的發展

Siemens Healthineers AG

公司簡介
公司收入
產品
最近的發展

Quest Diagnostics Inc.

公司簡介
公司收入
產品
最近的發展

Abbott BD

公司簡介
公司收入
產品
最近的發展

Bio-Rad Laboratories Inc.

公司簡介
公司收入
產品
最近的發展

Beckman Coulter Inc.

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112113943

The global demand for IVD In Cardiology And Neurology Market is presumed to reach the market size of nearly USD 39.57 Billion by 2032 from USD 16.88 Billion in 2023 with a CAGR of 9.93% under the study period 2024 - 2032.

In vitro diagnostics (IVD) in cardiology and neurology refers to diagnostic tests conducted on samples outside the body to assess heart and neurological conditions. These tests include biomarker measurements, genetic analyses, and imaging studies, aiding in the early detection, monitoring, and treatment planning of cardiovascular and neurological diseases.

MARKET DYNAMICS

The IVD (In Vitro Diagnostics) market in cardiology and neurology is driven by the rising prevalence of cardiovascular and neurological disorders globally. Technological advancements in IVD devices, such as biomarker discovery and molecular diagnostics, enhance diagnostic precision. Increased healthcare expenditures, a growing aging population, and proactive initiatives for preventive healthcare further stimulate market expansion. Additionally, integrating artificial intelligence and data analytics into IVD devices aids in personalized and efficient patient diagnostics. However, market restraints encompass challenges related to regulatory complexities and stringent approval processes for novel diagnostic technologies. Overcoming these restraints requires streamlined regulatory pathways and continued efforts to make advanced IVD technologies more accessible and cost-effective for healthcare providers in the cardiology and neurology market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of ivd in cardiology and neurology. The growth and trends of ivd in cardiology and neurology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the ivd in cardiology and neurology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Instruments
Reagents & Consumables
Software And Services

By Technology

Immunoassays
Molecular Diagnostics
Hematology
Others

By End-Use

Hospitals
Clinical Laboratories
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the IVD In Cardiology And Neurology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
Global IVD In Cardiology And Neurology Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the IVD In Cardiology And Neurology market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Sysmex Corp., Siemens Healthineers AG, Quest Diagnostics Inc., Abbott, BD, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc.This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . IVD IN CARDIOLOGY AND NEUROLOGY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By End-Use
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET ANALYSIS BY PRODUCT TYPE

5.1 Overview by Product Type
5.2 Historical and Forecast Data
5.3 Analysis by Product Type
5.4 Instruments Historic and Forecast Sales by Regions
5.5 Reagents & Consumables Historic and Forecast Sales by Regions
5.6 Software And Services Historic and Forecast Sales by Regions

6 . GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 Immunoassays Historic and Forecast Sales by Regions
6.5 Molecular Diagnostics Historic and Forecast Sales by Regions
6.6 Hematology Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET ANALYSIS BY END-USE

7.1 Overview by End-Use
7.2 Historical and Forecast Data
7.3 Analysis by End-Use
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Clinical Laboratories Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE IVD IN CARDIOLOGY AND NEUROLOGY COMPANIES

9.1. Ivd In Cardiology And Neurology Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF IVD IN CARDIOLOGY AND NEUROLOGY INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Thermo Fisher Scientific Inc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. F. Hoffmann-La Roche Ltd.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Sysmex Corp.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Siemens Healthineers AG
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Quest Diagnostics Inc.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Abbott BD
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Bio-Rad Laboratories Inc.
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Beckman Coulter Inc.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments